Seelos Therapeutics Inc. (NASDAQ: SEEL)
$0.57
+0.0488 ( +9.41% ) 389.3K
Seelos Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on developing products that address unmet needs in Central Nervous System (CNS) disorders and other rare disorders. Its product pipeline includes SLS-002, SLS-005, SLS-004, SLS-007, and SLS-009.
Market Data
Open
$0.57
Previous close
$0.52
Volume
389.3K
Market cap
$1.60M
Day range
$0.51 - $0.57
52 week range
$0.47 - $398.40
SEC Fillings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 8-k | 8K-related | 14 | Jul 16, 2024 |
| 8-k | 8K-related | 16 | Jul 12, 2024 |
| 8-k | 8K-related | 14 | Jun 05, 2024 |
| 8-k | 8K-related | 23 | May 21, 2024 |
| 8-k | 8K-related | 15 | May 16, 2024 |
| 10-q | Quarterly Reports | 68 | May 14, 2024 |
| 8-k | 8K-related | 15 | May 14, 2024 |
| 8-k | 8K-related | 14 | May 03, 2024 |
| 10-k/a | Quarterly Reports | 16 | Apr 29, 2024 |
| 8-k | 8K-related | 14 | Mar 28, 2024 |